Abstract
Viruses are frequent causes of respiratory infection, and viral respiratory infections are significant causes of hospitalization, morbidity, and sometimes mortality in a variety of patient populations. Lung inflammation induced by infection with common respiratory pathogens such as influenza and respiratory syncytial virus is accompanied by increased lung production of prostaglandins and leukotrienes, lipid mediators with a wide range of effects on host immune function. Deficiency or pharmacologic inhibition of prostaglandin and leukotriene production often results in a dampened inflammatory response to acute infection with a respiratory virus. These mediators may, therefore, serve as appealing therapeutic targets for disease caused by respiratory viral infection.
Highlights
Viruses are frequent causes of respiratory infection, and viral respiratory infections are significant causes of hospitalization, morbidity, and sometimes mortality in a variety of patient populations
Lung inflammation induced by infection with common respiratory pathogens such as influenza and respiratory syncytial virus is accompanied by increased lung production of prostaglandins and leukotrienes, lipid mediators with a wide range of effects on host immune function
Four isoforms of the EP3 receptor are coupled to different G proteins, the major EP3 receptor signaling pathway involves adenylate cyclase inhibition via Gαi coupling with subsequent decreases in intracellular cyclic antimicrobial peptides (AMPs) (cAMP) [10]
Summary
Viruses are the most frequent cause of respiratory infection in humans. The immune response to viruses can be protective, aiding with clearance of virus from the lungs and resolution of disease caused by viral replication. Disease associated with respiratory viruses can be caused by immune-mediated pathology. Virus-induced inflammation can be detrimental to the host, causing symptoms during acute infection and leading to damage that contributes to long-term residual lung disease. The prostaglandins (PGs) and leukotrienes (LTs), have been increasingly studied in the context of respiratory viral infection. Because of these effects, eicosanoids are likely to make significant contributions to the pathogenesis of respiratory virus infection
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have